Scholars@Duke
Matthew A. Sparks

Matthew A. Sparks

Associate Professor of Medicine
Medicine, Nephrology
matthew.sparks@duke.edu
DUMC Box 2747, Durham, NC 27710
DUMC Box 2747, 2424 Erwin Rd, Hock Nephrology Suite 605, Durham, NC 27705

Scholarly Works - Conferences

Impact of Treatment Modalities on Intensive Care Unit Length of Stay for Patients Admitted With Severe Hyponatremia.

Conference Ann Pharmacother · May 2026 BACKGROUND: The diversity in presentation and cause of hyponatremia leads to a wide array of treatment modalities which are selected based on severity, chronicity, volume status, and putative cause. Due to the variability in treatment selection, it is pert ... Full text Link to item Cite

COMPLEMENT-MEDIATED TMA IN A PATIENT WITH SCLERODERMA RENAL CRISIS

Conference AMERICAN JOURNAL OF KIDNEY DISEASES · April 2025 Link to item Cite

METHOTREXATE AND KIDNEY FUNCTION: DIFFERENTIAL EFFECTS OF HIGH VERSUS LOW-DOSE

Conference AMERICAN JOURNAL OF KIDNEY DISEASES · April 2025 Link to item Cite

The Duke Paired Undergraduate Mentoring Program in Uronephrology: PUMPing Up the Research Workforce

Conference Journal of the American Society of Nephrology · October 2024 Full text Cite

Abstract 525: Angiotensin Ii Type 1a Receptor Deletion In Vascular Smooth Muscle Cells Prevent Abdominal Aortic Aneurysm Formation Induced By Angiotensin Ii Plus β-aminopropionitrile

Conference Arteriosclerosis, Thrombosis, and Vascular Biology · May 2023 Abdominal aortic aneurysm (AAA) is multifactorial disease resulting from changes in the aortic wall structure, such as medial degradation and inflammation, causing life-threatening AAA rupture. Angiotensin II (AngII) type 1A receptor ( ... Full text Cite

RheumMadness: Early Learner Experience and Impact

Conference ARTHRITIS & RHEUMATOLOGY · September 2022 Link to item Cite